Atb Cap Markets reduced their Q3 2025 EPS estimates for shares of Organigram in a research report issued to clients and investors on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes now ...

Equities researchers at Alliance Global Partners raised their Q3 2025 EPS estimates for shares of Organigram in a research note issued to investors on Tuesday, February 11th. Alliance Global Partners ...

OrganiGram Holdings Inc (OGI) reports a 17% increase in net revenue and strategic international expansion, despite facing ...

Q1 2025 Earnings Call Transcript February 11, 2025 OrganiGram Holdings Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03. Operator: Good morning. My name is ...

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, ...

Reports Q1 adjusted EBITDA1 C$1.4M vs. C$0.1M in the prior year period. “This is an exciting time for Organigram (OGI) as we kick off Fiscal ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Organigram (OGI) to C$3 from C$4.25 and keeps a Buy rating on ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

OrganiGram Holdings Inc. (OGI) on Tuesday reported a loss of $16.4 million in its fiscal first quarter. The Toronto-based company said it had a loss of 14 cents per share.

My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the Organigram Holdings first-quarter fiscal 2025earnings conference call After ...